Panel Discussion: Gauging the Translational Relevance of Current Preclinical Platforms & Setting Industry Gold Standards

Time: 2:30 pm
day: Day One


• Discussing the use of multiplexed immunohistochemistry to understand tissue and tumor dynamics in the myeloid compartment

• Considering how to maintain myeloid cells ex vivo with in vivo phenotypes to minimize artefacts in assays

• Proposing a back-translation workflow to learn from mechanisms and feed them into drug design, as well as contrasting patent response vs. in vitro findings